BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.ads0539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Jiaming Wang und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Hauptthemen laut MEDLINE: Maple Syrup Urine Disease, Genetic Therapy, 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide), Homeostasis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Classic maple syrup urine disease (MSUD) results from biallelic mutations in genes that encode the branched-chain α-ketoacid dehydrogenase E1 α ( BCKDHA ), E1 β ( BCKDHB ), or dihydrolipoamide branched-chain transacylase ( DBT ) subunits, which interact to form the mitochondrial BCKDH complex that decarboxylates ketoacid derivatives of leucine, isoleucine, and valine. MSUD is an inborn error of metabolism characterized by recurrent life-threatening neurologic crises and progressive brain injury that can only be managed with an exacting prescription diet or allogeneic liver transplant. To develop a gene replacement therapy for MSUD, we designed a dual-function recombinant adeno-associated virus serotype 9 (rAAV9) vector to deliver codon-optimized BCKDHA and BCKDHB (rAAV9.h A -BiP-h B ) to the liver, muscle, heart, and brain. rAAV9.h A -BiP-h B restored coexpression of BCKDHA and BCKDHB as well as BCKDH holoenzyme activity in BCKDHA −/− HEK293T cells and did not perturb physiologic branched-chain amino acid homeostasis in wild-type mice at a systemic dose of 2.7 × 10 14 vector genomes per kilogram. In two models of severe MSUD ( Bckdha −/− and Bckdhb −/− mice) and a newborn calf homozygous for BCKDHA c.248C>T, one postnatal injection prevented perinatal death, normalized growth, restored coordinated expression of BCKDHA and BCKDHB in the skeletal muscle, liver, heart, and brain, and stabilized MSUD biomarkers in the face of high protein ingestion. In summary, we developed a one-time BCKDHA-BCKDHB systemic dual-gene replacement strategy that holds promise as a therapeutic alternative to prescription diet and liver transplant for treatment of MSUD types 1A and 1B, the two most common forms of MSUD in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetic and Cellular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
- Clinic for Special Children, Gordonville, PA 17529, USA.
- Department of Biochemistry, University of Texas Southwestern Medical School, Dallas, TX 75390, USA.
- Department of Animal Science and Large Animal Clinical Sciences, University of Tennessee Institute of Agriculture, Knoxville, TN 37996, USA.
- Longview Farms, New Virginia, IA 50210, USA.
- Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA.
ORCID-Profile: Jiaming Wang, Laura E Poskitt, Jillian Gallagher, Karlla W Brigatti, William C Baker, Rachael Gately, Hector R Benatti, Toloo Taghian, Rachel Prestigiacomo, Gong Chen, Xuntao Zhou, Nan Liu, Jun Xie, Alisha Gruntman, Heather Gray-Edwards, Guangping Gao, Kevin A Strauss, Dan Wang
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NINDS NIH HHS
Zitieren
APA
Wang, J., Poskitt, L. E., Gallagher, J., Puffenberger, E. G., Wynn, R. M., Shishodia, G., Chuang, D. T., Beever, J., Hardin, D. L., Brigatti, K. W., Baker, W. C., Gately, R., Bertrand, S., Rodrigues, A., Benatti, H. R., Taghian, T., Hall, E., Prestigiacomo, R., Liang, J., …, & Wang, D. (2025). BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ads0539
Vancouver
Wang J, Poskitt LE, Gallagher J, Puffenberger EG, Wynn RM, Shishodia G, et al. BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ads0539
BibTeX
@article{Wang2025,
author = {Wang, Jiaming and Poskitt, Laura E and Gallagher, Jillian and Puffenberger, Erik G and Wynn, R Max and Shishodia, Gauri and Chuang, David T and Beever, Jonathan and Hardin, Donald L and Brigatti, Karlla W and Baker, William C and Gately, Rachael and Bertrand, Stephanie and Rodrigues, Ashlin and Benatti, Hector R and Taghian, Toloo and Hall, Erin and Prestigiacomo, Rachel and Liang, Jialing and Chen, Gong and Zhou, Xuntao and Ren, Lingzhi and Liu, Nan and He, Ran and Su, Qin and Xie, Jun and Jiang, Zhong and Gruntman, Alisha and Gray-Edwards, Heather and Gao, Guangping and Strauss, Kevin A and Wang, Dan},
title = {BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.ads0539}
}
EUVIMED